Glial Cell

Changes in blood-based biomarkers suggested long-duration spaceflight may pose risks for humans, according to a research letter published in JAMA Neurology.

In this video from the Annual Meeting of the American Neurological Association, Jennifer Orthmann-Murphy, MD, PhD, reviews the plenary session she chaired that highlighted current research on targeting glia cells for therapy.